| 05/06 | Wedbush Adjusts Price Target on Omega Therapeutics to $24 From $30, Keeps Outperform Ra.. | MT |
| 05/04 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,.. | CI |
| 04/29 | Omega Therapeutics Hires Aldeyra Therapeutics Chief Financial Officer Joshua Reed for S.. | MT |
| 04/29 | Omega Therapeutics Announces Appointment of Joshua Reed as Chief Financial Officer | PR |
| 04/29 | Omega Therapeutics Announces Appoints Joshua Reed as Chief Financial Officer, Effective.. | CI |
| 04/29 | Omega Therapeutics, Inc. Announces Executive Changes | CI |
| 03/30 | Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Gro.. | PR |
| 03/30 | Omega Therapeutics Inc. Announces Executive Changes | CI |
| 03/11 | Wedbush Adjusts Omega Therapeutics' Price Target to $30 From $36, Keeps Outperform Rati.. | MT |
| 03/10 | SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
| 03/10 | SECTOR UPDATE : Health Care | MT |
| 03/10 | OMEGA THERAPEUTICS : Reports Fourth Quarter and Full Year 2021 Financial Results and Outli.. | PU |
| 03/10 | Omega Therapeutics Q4 Net Loss Narrows | MT |
| 03/10 | Omega Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December.. | CI |
| 03/10 | Omega Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, .. | CI |
| 01/26 | Certain Common Stock of Omega Therapeutics, Inc. are subject to a Lock-Up Agreement End.. | CI |
| 01/26 | Certain Stock Options of Omega Therapeutics, Inc. are subject to a Lock-Up Agreement E.. | CI |
| 01/26 | Certain Warrants of Omega Therapeutics, Inc. are subject to a Lock-Up Agreement Ending .. | CI |
| 01/10 | Omega Therapeutics Announces Appointment of Yan Moore, M.D., as Chief Medical Officer | PR |
| 01/10 | Omega Therapeutics Announces Appointment of Yan Moore as Chief Medical Officer | CI |
| 2021 | Omega Therapeutics, Inc. and Pacific Western Bank Enters into the Fourth Amendment to t.. | CI |
| 2021 | OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to S&P Global BMI Index | CI |
| 2021 | OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to NASDAQ Biotechnology Index | CI |
| 2021 | Omega Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare C.. | PR |
| 2021 | Omega Therapeutics Narrows Loss in Q3 | MT |
| 2021 | Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corpor.. | PU |
| 2021 | Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corpor.. | PR |
| 2021 | Omega Therapeutics to Present at the Jefferies London Healthcare Conference | PR |
| 2021 | OMEGA THERAPEUTICS : Working With Stanford University to Explore Use of Omega Epigenomic C.. | MT |
| 2021 | OMEGA THERAPEUTICS : Announces Strategic Research Collaboration with Stanford University S.. | PR |
| 2021 | Omega Therapeutics, Inc. Announces Strategic Research Collaboration with Stanford Unive.. | CI |
| 2021 | TRANSCRIPT : Omega Therapeutics, Inc. Presents at Chardan's 5th Annual Genetic Medicines C.. | CI |
| 2021 | OMEGA THERAPEUTICS : to Present at the Chardan Virtual 5th Annual Genetic Medicines Confer.. | PR |
| 2021 | OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to S&P TMI Index | CI |
| 2021 | OMEGA THERAPEUTICS' : Q2 Loss Widens as Operating Expenses Rise | MT |
| 2021 | OMEGA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Outlines Key Corpor.. | PR |
| 2021 | Omega Therapeutics, Inc. Announces Unaudited Earnings Results for the Second Quarter an.. | CI |
| 2021 | OMEGA THERAPEUTICS : Jefferies Starts Omega Therapeutics at Buy With $30 Price Target | MT |
| 2021 | OMEGA THERAPEUTICS : Goldman Sachs Starts Omega Therapeutics at Neutral With $22 Price Tar.. | MT |
| 2021 | OMEGA THERAPEUTICS : Piper Sandler Starts Omega Therapeutics at Overweight With $30 Price .. | MT |
| 2021 | OMEGA THERAPEUTICS : Wedbush Starts Omega Therapeutics at Outperform With $36 Price Target | MT |
| 2021 | OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to NASDAQ Composite Index | CI |
| 2021 | OMEGA THERAPEUTICS : Falls in Nasdaq Debut After Pricing IPO at Midpoint of Expected Range | MT |
| 2021 | OMEGA THERAPEUTICS : Prices IPO at Midpoint of Expected Range at $17 Per Share | MT |
| 2021 | OMEGA THERAPEUTICS : Announces Pricing of Initial Public Offering | PR |
| 2021 | Omega Therapeutics, Inc. has completed an IPO in the amount of $125.8 million. | CI |
| 2021 | Omega Therapeutics, Inc. has filed an IPO in the amount of $100 million. | CI |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
